Fecal microbiota transplantation relieve painful diabetic neuropathy: A case report

• Published in: Medicine (Baltimore) Vol. 97; no. 50; p. e13543
• Main Authors: Cai, Ting-Ting, Ye, Xiao-Long, Yong, Hui-Juan, Song, Bin, Zheng, Xiao-Ling, Cui, Bo-Ta, Zhang, Fa-Ming, Lu, Yi-Bing, Miao, Heng, Ding, Da-Fa
• Format: Journal Article
• Language: English
• Published: United States Wolters Kluwer Health 01.12.2018
• Subjects: Clinical Case Report; Diabetic Neuropathies - microbiology; Diabetic Neuropathies - surgery; Fecal Microbiota Transplantation - methods; Female; Humans; Middle Aged; Remission Induction - methods
• ISSN: 0025-7974; 1536-5964
• DOI: 10.1097/MD.0000000000013543

Fecal microbiota transplantation (FMT) has been used in a wide variety of diseases. In this article, we reported a 46-year-old female with diabetic neuropathy (DN) achieved remission by the treatment of FMT. The patient with an 8-year history of diabetes and hypertension was admitted to hospital due to sensitive pain of her right thigh and poor blood glucose control. The traditional hypoglycemic and analgesic treatment were useless to her symptoms. Diabetic-induced neuropathy was considered. This patient received twice FMTs for 3 months. After twice FMTs, the clinical response of patient was pleasant. The glycemic control was improved, with a remarkable relief of the symptoms of painful DN in particular. No obvious adverse effects were observed during the FMTs and follow-up observation-testing. We proposed that FMT could be a promising treatment in patients with diabetes or diabetes-related complications like DN. FMT also appeared to be definitely safer and more tolerable than the pharmacologic treatment in patients with DN.